Inflammatory Bowel Disease (IBD) is a group of inflammatory conditions of the colon and small intestine. The major types of IDB are Crohn’s Disease and ulcerative colitis. In the US, approximately 1 million people suffer from diseases that fall under the category of IBD. Treatments for this disease ordinarily include steroids and immune-suppressors. However, researchers at Wake Forest have recently discovered a population of stem cells that may be able to treat IBD without the use of either steroids or immune-suppressors.
"These cells are involved in the formation of blood vessels and may prove to be a tool for improving the vessel abnormalities found in IBD," said lead researcher Graca Almeida-Porada, M.D., Ph.D., a professor at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine. Because these stem cells target the intestine on their own, if they can be programmed to begin regenerating a damaged intestine or colon, they could be used as a treatment for those with IBD simply by an injection of these cells.
Dr. Almeida-Porada’s cutting edge research demonstrates the paradigm shift in medical treatments that are being driven by advances in regenerative medicine. As new applications for stem cells – the body’s natural repair and maintenance mechanism - are developed, the best stem cells to use will be your own [autologous] stem cells. One of the best sources of autologous stem cells is from the dental pulp of teeth. To learn how to bank your own valuable stem cells to ensure access to emerging regenerative therapies, visit www.stemsave.com or call 877-783-6728 877-StemSave) today.
To view the full article, click here.
The future of Regenerative Medicine is now™.